Analysis of Mipox Corporation (5381)
Mipox Corporation, with the symbol 5381, has shown some interesting trends in its recent stock price movements.
Looking at the technical indicators, the Relative Strength Index (RSI) has been fluctuating around the 40-50 range, indicating a neutral stance in terms of momentum. The Moving Average Convergence Divergence (MACD) has been negative, suggesting a bearish trend, although the MACD histogram has shown some signs of stabilization.
In terms of moving averages, the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) have been relatively close to each other, indicating a consolidation phase in the stock price.
Overall, Mipox Corporation seems to be in a consolidation phase with a slightly bearish bias based on the technical indicators. Traders and investors may want to closely monitor the RSI and MACD indicators for potential signals of a trend reversal.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.
In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and the most recent quarter reported is March 2024. The company shows good returns on assets and equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock has a beta of 1.264 and has shown a slight increase in the fifty-two-week range.
Valuation metrics show a relatively high PEG ratio and price-to-book ratio. The company's market capitalization and enterprise value are substantial, with moderate price-to-sales and enterprise-to-EBITDA ratios.
The stock price summary includes moving averages, fifty-two-week high and low prices, and beta value.
Lastly, dividends and splits information shows the company's dividend dates, payout ratios, and dividend yields. The company has a history of dividends and stock splits, with a forward annual dividend rate and a 5-year average dividend yield provided.
Income statement 💸
These are the revenue figures. Here are the conclusions:
1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite fluctuations in other financial metrics, the gross profit has generally followed the trend of increasing sales revenue.
3. The company has been able to maintain a healthy EBITDA margin, with EBITDA reaching $129.2 billion in 2023.
4. Net income has also shown an increasing trend, reaching $97 billion in 2023 from $57.4 billion in 2020.
5. Earnings per share (EPS) have been relatively stable over the years, with slight fluctuations but no significant downward trends.
6. The company has managed its operating expenses effectively, with operating income consistently growing over the years.
7. Despite variations in non-operating interests and other income/expenses, the company has been able to sustain its profitability and financial performance.
8. The number of basic and diluted shares outstanding has remained relatively stable over the years.
Overall, the company has demonstrated strong revenue growth, effective cost management, and consistent profitability over the years.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2019 at $90,488,000,000.
6. The company seems to be investing more in non-current assets over the years.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show significant fluctuations, especially in common stock repurchases and long-term debt issuances.
6. Investing activities also vary, with notable amounts spent on the sale and purchase of investments.
7. Overall, the company's financial performance seems to be stable, with some fluctuations in key financial indicators.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share (EPS), we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter last year, as projected by 27 analysts.
2. Looking at the next quarter ending on September 30, 2024, analysts forecast an average EPS of $1.42, ranging from a low estimate of $1.33 to a high estimate of $1.51. The EPS is expected to be higher than the $1.35 reported in the same quarter a year ago, based on the projections of 26 analysts.
3. For the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.10, with a low estimate of $5.95 and a high estimate of $6.41. This reflects an increase from the EPS of $5.67 in the previous fiscal year, as analyzed by 40 analysts.
4. Looking ahead to the next fiscal year ending on September 30, 2025, analysts anticipate an average EPS of $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This shows growth compared to the EPS of $6.10 in the current fiscal year, as projected by 40 analysts.
In summary, the analysts' estimates suggest a positive trend in earnings per share for both the upcoming quarters and the next fiscal years, indicating potential growth and improvement in the company's financial performance.
Revenue estimate
The analysts' estimates for the future quarterly and annual sales of the company indicate a moderate growth trend.
For the current quarter ending on June 30, 2024, the average estimate is $77,545,400,000, representing a 2% increase from the same quarter last year. The number of analysts providing estimates is 25.
Looking ahead to the next quarter ending on September 30, 2024, the average estimate is $85,501,800,000, with a sales growth of 3% compared to the previous year. The number of analysts remains at 25.
For the current fiscal year ending on September 30, 2024, the average estimate is $357,772,000,000, showing a 1% growth from the previous year. The number of analysts providing estimates for the annual sales is 38.
In the following fiscal year ending on September 30, 2025, the average estimate is $380,772,000,000, indicating a more significant growth of 6% from the current fiscal year. The number of analysts remains at 38.
Overall, the estimates suggest a steady growth trajectory for the company's sales in both the short term and the long term, with a slightly more optimistic outlook for the upcoming fiscal year.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:
1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is slightly higher at 5.2%.
3. Current Year: The growth rate for the current year is estimated to be 7.6%.
4. Next Year: The growth rate for the next year is expected to increase to 9.7%.
5. Past 5 Years (per annum): Over the past 5 years, the company has shown a growth rate of approximately 20.1% per year.
6. Next 5 Years (per annum): Looking ahead, analysts project a growth rate of around 9.7% per year for the next 5 years.
These estimates suggest a positive outlook for the company, with a gradual increase in growth rate expected in the upcoming periods compared to the current and past performance.
Price target
The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median forecast above the current price. However, there is a wide range of estimates, from a low of $164 to a high of $275, indicating some uncertainty in the predictions.MACD of 5381